Screener
Immunovant, Inc. IMVT Business Segments — Personnel-related general and administrative
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026.
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
| Line item | Years Ended March 31, 2026 | Years Ended March 31, 2025 | Years Ended March 31, 2024 |
|---|---|---|---|
| Contractual costs related to batoclimab program discontinuation | 38,952 | — | — |
| Personnel-related research and development (1) | 128,534 | 111,499 | 74,290 |
| Acquired in-process research and development | — | — | 12,500 |
| Personnel-related general and administrative (2) | 48,730 | 41,095 | 34,684 |
| Other general and administrative (3) | 27,512 | 36,140 | 22,597 |
| Interest income, net | (25,330) | (24,732) | (24,948) |
| Other segment items (4) | (1,966) | 420 | 1,575 |
| Net loss | $505,606 | $413,840 | $259,336 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Immunovant, Inc.'s business segments — personnel-related general and administrative?
- Immunovant, Inc. (IMVT) reported business segments — personnel-related general and administrative of $10.13M in Q1 2026.
- How has Immunovant, Inc.'s business segments — personnel-related general and administrative changed year-over-year?
- Immunovant, Inc.'s business segments — personnel-related general and administrative increased by 8.9% year-over-year, from $9.3M to $10.13M.
- What is the long-term trend for Immunovant, Inc.'s business segments — personnel-related general and administrative?
- Over 3 years (2023 to 2026), Immunovant, Inc.'s business segments — personnel-related general and administrative has grown at a 20.4% compound annual growth rate (CAGR), from $27.91M to $48.73M.
- What does business segments — personnel-related general and administrative mean?
- Includes all salary, benefits, and related compensation costs for administrative and support staff within the reportable segment. This metric reflects the fixed operational overhead required to manage the business, excluding direct research activities. It serves as a key measure of the company's administrative efficiency and organizational scaling.
Ask your AI about Immunovant, Inc.'s business segments — personnel-related general and administrative.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude